New award for bupropion tablets with major. Period of performance is 3/1/2025-2/28/2026 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0010
- Awardee
-
The Harvard Drug Group, L.L.C. UEI CBGGKKVNJBK9 Part of Cardinal Health, Inc.
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Bupropion Tablets Pre-Solicitation · 36E79724R0029 · Posted Sep 3, 2024
- Last date to order 85% complete
- IDV ceiling
- $2,936,792.25
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded a single-award indefinite-delivery contract to The Harvard Drug Group, L.L.C. for bupropion tablets with a ceiling of $2,936,792.25 on March 1, 2025. The awardee is a Native Hawaiian Organization-owned subsidiary. Performance occurs at the vendor's La Vergne, Tennessee location. The solicitation sought an unrestricted procurement of Bupropion Hydrochloride tablets in 100mg and 75mg formulations, with estimated annual usage of 51,786 bottles of 100mg tablets and 107,205 bottles of 75mg tablets, for distribution through the Veterans Affairs and Defense Department Pharmaceutical Prime Vendor Programs. The contract carries a one-year base period running March 1, 2025, through February 28, 2026, with four one-year options. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing) and PSC code is 6505 (Drugs and Biologicals). The pre-solicitation was posted September 3, 2024, with a due date of September 30, 2024. The contract is issued in commercial item format under FAR Part 12. The award implements Executive Order 14398 addressing DEI discrimination by federal contractors.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Vendor Address Change | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0010?
36E79725D0010 was awarded to The Harvard Drug Group, L.L.C. by National Acquisition Center (Headquarters) on March 1, 2025.
How much is contract 36E79725D0010 worth?
36E79725D0010's own ceiling is $2,936,792.
Who can order from contract 36E79725D0010?
36E79725D0010 is a single award indefinite delivery contract.
Was contract 36E79725D0010 competed?
The extent of competition for 36E79725D0010 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV